statistiche ricercatore

Continente	#
NA - Nord America	394
AS - Asia	296
EU - Europa	239
SA - Sud America	47
AF - Africa	23
Continente sconosciuto - Info sul continente non disponibili	16
OC - Oceania	1
Totale	1.016

Nazione	#
US - Stati Uniti d'America	378
SG - Singapore	98
CN - Cina	76
IT - Italia	46
IE - Irlanda	45
HK - Hong Kong	40
VN - Vietnam	38
BR - Brasile	34
DE - Germania	33
RU - Federazione Russa	32
FI - Finlandia	17
FR - Francia	17
ZA - Sudafrica	15
GB - Regno Unito	14
CA - Canada	9
AT - Austria	8
BD - Bangladesh	8
IN - India	7
ES - Italia	5
NL - Olanda	5
TR - Turchia	5
CZ - Repubblica Ceca	4
UZ - Uzbekistan	4
CO - Colombia	3
EC - Ecuador	3
PL - Polonia	3
SA - Arabia Saudita	3
AR - Argentina	2
DO - Repubblica Dominicana	2
JP - Giappone	2
KE - Kenya	2
MA - Marocco	2
MX - Messico	2
NP - Nepal	2
PK - Pakistan	2
PY - Paraguay	2
SE - Svezia	2
AD - Andorra	1
AU - Australia	1
BA - Bosnia-Erzegovina	1
BE - Belgio	1
BO - Bolivia	1
CH - Svizzera	1
CR - Costa Rica	1
EG - Egitto	1
ET - Etiopia	1
GD - Grenada	1
GE - Georgia	1
GR - Grecia	1
HR - Croazia	1
ID - Indonesia	1
IL - Israele	1
JO - Giordania	1
KZ - Kazakistan	1
LB - Libano	1
LK - Sri Lanka	1
LT - Lituania	1
LY - Libia	1
MY - Malesia	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TN - Tunisia	1
VE - Venezuela	1
Totale	1.000

Nome	#
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis	122
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs	122
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis	118
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients	103
Novel Therapies for ANCA-associated Vasculitis	101
A 28-Year-Old Man with Stridor and Dyspnea	97
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment	91
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study	88
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis	88
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study	86
Totale	1.016

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	12	0	0	3	0	0	0	0	1	0	0	2	6
2022/2023	110	6	6	0	15	8	11	0	4	48	0	4	8
2023/2024	106	14	23	4	10	4	20	8	7	1	0	7	8
2024/2025	221	11	10	0	2	5	20	18	15	45	22	22	51
2025/2026	520	51	38	51	49	61	24	81	35	60	30	25	15
2026/2027	38	7	23	8	0	0	0	0	0	0	0	0	0
Totale													1.016